BNTX — BioNTech SE stock price, charts and financials

QT37BioNTech SE

BioNTech SE (NASDAQ: BNTX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
93.09
-0.58-0.62%
OverviewShort InterestFilings
BNTXQT37BioNTech SE·NASDAQ
93.09-0.62%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 20266-KForeign issuer report
Aug 04, 20266-KForeign issuer report
Aug 03, 20266-KForeign issuer report
Jul 30, 202620-F/A20-F/A
Jul 29, 20266-KForeign issuer report
Jun 26, 20263Initial statement of beneficial ownership
Jun 26, 20263Initial statement of beneficial ownership
Jun 08, 20266-KForeign issuer report
Jun 01, 20266-KForeign issuer report
May 22, 20266-KForeign issuer report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 20266-KForeign issuer report
May 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 07, 20266-KForeign issuer report
May 05, 20266-KForeign issuer report
May 05, 20266-KForeign issuer report
Apr 23, 20264Statement of changes in beneficial ownership
Apr 13, 20263/AInitial statement of beneficial ownership (amended)
Apr 13, 20266-KForeign issuer report
Apr 02, 20266-KForeign issuer report
#1 / 25 of 317
Page
▼
/ 13